RP
AMED

Riverbridge Partners’s Amedisys AMED Stock Holding History

Riverbridge Partners’s Portfolio AMED Stock Details AMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-2,235
Closed -$209K – 203
2023
Q3 		$209K Sell
2,235
-1,557,337
-100% -$144M ﹤0.01% 186
2023
Q2 		$143M Buy
1,559,572
+34,261
+2% +$2.81M 1.8% 18
2023
Q1 		$112M Sell
1,525,311
-582
-0% -$50.4K 1.57% 21
2022
Q4 		$127M Sell
1,525,893
-102,380
-6% -$9.23M 1.91% 14
2022
Q3 		$158M Buy
1,628,273
+123,286
+8% +$14.7M 2.34% 10
2022
Q2 		$158M Sell
1,504,987
-188,669
-11% -$24.1M 2.53% 6
2022
Q1 		$292M Buy
1,693,656
+104,906
+7% +$15.7M 3.3% 2
2021
Q4 		$257M Buy
1,588,750
+576,633
+57% +$92.7M 2.54% 6
2021
Q3 		$151M Sell
1,012,117
-4,506
-0.4% -$937K 1.51% 20
2021
Q2 		$249M Buy
1,016,623
+98,725
+11% +$25.9M 2.53% 5
2021
Q1 		$243M Buy
917,898
+178,664
+24% +$50.4M 2.77% 5
2020
Q4 		$217M Buy
739,234
+45,291
+7% +$11.6M 2.4% 6
2020
Q3 		$164M Buy
693,943
+21,874
+3% +$4.97M 2.29% 9
2020
Q2 		$133M Buy
672,069
+11,328
+2% +$2.11M 2.09% 14
2020
Q1 		$121M Sell
660,741
-3,198
-0.5% -$569K 2.54% 6
2019
Q4 		$111M Sell
663,939
-5,078
-0.8% -$755K 1.99% 16
2019
Q3 		$87.6M Buy
669,017
+6,261
+0.9% +$815K 1.66% 20
2019
Q2 		$80.5M Buy
+662,756
New +$78.7M 1.52% 24

Other funds holding AMED

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
WCMNY
Westchester Capital Management (New York) Valhalla, New York $2.21B AUM 26.02% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return
PWAM
Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return

Riverbridge Partners's AMED Position: Q4 2023 in Review

Riverbridge Partners sold out of Amedisys (AMED) in Q4 2023, closing a stake of 2,235 shares — an estimated $209K sold.

Riverbridge Partners first reported a position in AMED in Q2 2019 and held it in 18 quarters. The position peaked at $292M in Q1 2022. 287 funds tracked by Wall St. Rank hold AMED as of Q4 2023.

  • Riverbridge Partners reported no remaining Amedisys position as of Q4 2023 after selling out during the quarter.
  • Riverbridge Partners sold 2,235 Amedisys shares in Q4 2023, an estimated $209K.
  • Riverbridge Partners first reported a position in Amedisys in Q2 2019 and held it in 18 quarters.
  • Riverbridge Partners's Amedisys position peaked at $292M in Q1 2022.
  • 287 funds tracked by Wall St. Rank held Amedisys as of Q4 2023.

Based on Riverbridge Partners's 13F filing for Q4 2023, filed 24 Jan 2024.